Xeris Pharmaceuticals | XERS - Market Capitalization

Stock Price
6.24
Daily Change
-0.14 -2.19%
Monthly
1.96%
Yearly
27.87%
Q2 Forecast
6.11

Xeris Pharmaceuticals reported $896.1M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Celltrion KRW 42.71T 908.1B May/2026
Cspc Pharmaceutical CNY 87.29B 19.74B Dec/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Nektar Therapeutics USD 15.62B 14.76B May/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.58B 265M May/2026
Pharma Mar EUR 1.7B 128.17M May/2026
Qiagen NV USD 6.43B 1.85B May/2026
Sartorius EUR 14.25B 2.16B Mar/2026
Supernus Pharmaceuticals USD 2.82B 155M May/2026
Zealand Pharma A/S 33.35B 448.34M Dec/2025